duration

持续时间
  • 文章类型: Journal Article
    目的:本研究的目的是探讨老年心力衰竭(HF)住院患者物理治疗(PT)的频率和持续时间与住院相关残疾(HAD)发展之间的关系。
    方法:这种单中心,回顾性,观察性研究纳入了接受PT治疗的65岁或以上的HF住院患者.有关人口统计的数据,合并症,实验室发现,药物,康复,并从电子病历中收集日常生活活动(ADLs)状态。根据PT的平均频率和持续时间,患者分为三组:第1组,≥3天/周和≥120分钟/周;第2组,≥3天/周和<120分钟/周;第3组,<3天/周和<120分钟/周.进行Logistic回归分析以确定每周PT的平均频率和持续时间与HAD发生率之间的关联。
    结果:总而言之,105名患者(平均年龄,84.8岁;妇女比例,59%)参加了研究,43例(41.0%)患者出院时出现HAD。在多变量逻辑回归分析中,第2组(赔率比[OR],3.66)和第3组(OR,6.71)使用第1组作为参考,发生HAD的风险显着升高,即使在调整了年龄之后,入院前的ADL,认知功能,HF的严重程度。
    结论:这项研究表明,在老年心力衰竭住院患者中,PT的频率较低和持续时间较短与HAD的发生有关。然而,需要进一步的前瞻性研究来证实这些发现.
    OBJECTIVE: The aim of this study was to examine the relationship between the frequency and duration of physical therapy (PT) and the development of hospitalization-associated disability (HAD) in hospitalized geriatric patients with heart failure (HF).
    METHODS: This single-center, retrospective, observational study included hospitalized patients with HF aged 65 years or older who had received PT. Data regarding demographics, comorbidities, laboratory findings, medications, rehabilitation, and activities of daily living (ADLs) status were collected from electronic medical records. Based on the average frequency and duration of PT, patients were divided into three groups: Group 1, ≥3 days/week and ≥120 minutes/week; Group 2, ≥3 days/week and <120 minutes/week; and Group 3, <3 days/week and <120 minutes/week. Logistic regression analysis was performed to identify the association between the average frequency and duration of weekly PT and the incidence of HAD.
    RESULTS: In all, 105 patients (mean age, 84.8 years; proportion of women, 59%) were enrolled in the study, and 43 (41.0%) patients exhibited HAD at discharge. In the multivariate logistic regression analysis, Group 2 (odds ratio [OR], 3.66) and Group 3 (OR, 6.71) had a significantly elevated risk of developing HAD using Group 1 as the reference, even after adjusting for age, ADLs before admission, cognitive function, and severity of HF.
    CONCLUSIONS: This study showed that a lower frequency and shorter duration of PT are associated with developing HAD in hospitalized geriatric patients with HF. However, further prospective studies are required to confirm these findings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:大多数对设备检测到的心房颤动(AF)的研究都建议在患者超过房颤持续时间或负担的特定阈值时进行不确定的抗凝治疗。然而,已知持续时间和负担会随着时间的推移而波动,但对自发性波动的幅度和对抗凝决策的潜在影响知之甚少.
    目的:量化植入式环路记录仪(ILRs)患者的房颤持续时间和负担的自发波动方法:我们回顾了2018年至2023年在我们机构对非永久性房颤患者的所有ILR询问。我们排除了节律控制治疗的患者。每次询问时房颤发作的最长持续时间分为<6、6-24和>24小时。每次审讯时报告的房颤负担被归类为<2%,2%-11.4%,和>11.4%。
    结果:在156名患者中,ILR植入的平均年龄为70.9±12.5岁,CHA2DS2-VASc评分为4.2±1.8,ILR随访时间为23.4±11.2个月,每位患者的ILR询问次数为18.0±8.9.随访期间任何时间点的最长AF发作持续时间<6,6-24,110、30和16例患者>24小时,分别。在30例房颤发作最长6-24小时的患者中,在随访期间的某个时间点,在总共594次ILR审讯中,只有75(12%)显示最长的6-24小时发作。在其余的519次审讯中,最长的发作时间<6小时。在随访期间任何时间点最长的发作时间>24小时的患者(n=16),320次总ILR询问中只有47次(15%)显示>24小时的发作。评估房颤负担时,96、38和22例患者的最大房颤负担报告<2%,2%-11.4%,在ILR随访期间的任何时间点都>11.4%。在随访期间某个时间点的最大负担为2%-11.4%的患者中(n=38),在707次ILR审讯中,只有76人(11%)显示2%-11.4%的负担。在剩下的631次审讯中,负担<2%。在随访期间的某个时间点,负担>11.4%的22例患者中,480次审讯中只有80次(17%)显示负担>11.4%。在65%的审讯中,负担<2%。
    结论:重要,房颤负荷和持续时间的自发波动在ILRs患者中很常见.即使在随访期间某个时间点房颤发作6-24小时或>24小时的患者,绝大多数审讯显示<6小时的情节。同样,在随访期间的某个时间点,负担为2%-11.4%或>11.4%的患者,绝大多数审讯显示负担<2%。需要更多的数据来确定是否超过房颤负荷或持续时间阈值一次就足以值得终身抗凝,或者房颤负荷和持续时间的自发波动是否会影响抗凝决策。
    BACKGROUND: Most studies of device-detected atrial fibrillation (AF) have recommended indefinite anticoagulation once a patient crosses a particular threshold for AF duration or burden. However, durations and burdens are known to fluctuate over time, but little is known about the magnitude of spontaneous fluctuations and the potential impact on anticoagulation decisions.
    OBJECTIVE: To quantify spontaneous fluctuations in AF duration and burden in patients with implantable loop recorders (ILRs) METHODS: We reviewed all ILR interrogations for patients with non-permanent AF at our institution from 2018 to 2023. We excluded patients treated with rhythm control. The duration of longest AF episode at each interrogation was classified as < 6, 6-24, and > 24 h, and the AF burden reported at each interrogation was classified as < 2%, 2%-11.4%, and > 11.4%.
    RESULTS: Out of 156 patients, the mean age at ILR implant was 70.9 ± 12.5 years, CHA2DS2-VASc score was 4.2 ± 1.8, duration of ILR follow-up was 23.4 ± 11.2 months, and number of ILR interrogations per patient was 18.0 ± 8.9. The duration of longest AF episode at any point during follow-up was < 6 , 6-24 , and > 24 h in 110, 30, and 16 patients, respectively. Among the 30 patients with a longest AF episode of 6-24 h at some point during follow-up, out of 594 total ILR interrogations, only 75 (12%) showed a longest episode of 6-24 h. In the remaining 519 interrogations, the longest episode was < 6 h. In patients with a longest episode of > 24 h at any point during follow-up (n = 16), only 47 out of 320 total ILR interrogations (15%) showed an episode of > 24 h. When evaluating AF burden, 96, 38, and 22 patients had maximum reported AF burdens of < 2%, 2%-11.4%, and > 11.4% at any point during ILR follow-up. Among those with a maximum burden of 2%-11.4% at some point during follow-up (n = 38), out of 707 ILR interrogations, only 76 (11%) showed a burden of 2%-11.4%. In the remaining 631 interrogations, the burden was < 2%. In the 22 patients with a burden > 11.4% at some point during follow-up, only 80 out of 480 interrogations (17%) showed a burden of > 11.4%. In 65% of interrogations, the burden was < 2%.
    CONCLUSIONS: Significant, spontaneous fluctuations in AF burden and duration are common in patients with ILRs. Even in patients with AF episodes of 6-24 h or > 24 h at some point during follow-up, the vast majority of interrogations show episodes of < 6 h. Similarly, in patients with burdens of 2%-11.4% or > 11.4% at some point during follow-up, the vast majority of interrogations show burdens of < 2%. More data are needed to determine whether crossing an AF burden or duration threshold once is sufficient to merit lifelong anticoagulation or whether spontaneous fluctuations in AF burden and duration should impact anticoagulation decisions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    由于气候变化和人类干预的影响,全球河流正在变暖。这项研究调查了维斯瓦河流域的河流热浪,欧洲最大的河流系统之一,使用过去30年(1991-2020年)的长期观测的每日河水温度。结果表明,维斯杜拉河流域的河流热浪频率和强度均有所增加。河流热浪总数呈明显上升趋势,平均为1.400次/十年,河流热浪的持续时间平均以14.506天/十年的速度增加,河流热浪的累积强度以平均53.169°C/十年的速率增加。还采用了曼-肯德尔(MK)测试,显示出总数在统计上显着的增长趋势,持续时间,所有河流的热浪强度,包括维斯瓦河及其支流的主要水道,除了少数例外。气温是各水文站河流热浪的主要控制者,随着气温的升高,河流热浪的频率和强度将增加。另一个影响因素是流动,随着流量的增加,河流热浪的数量趋于减少,持续时间和强度。结果表明,应采取缓解措施,以减少气候变化对河流系统的影响。
    Rivers worldwide are warming due to the impact of climate change and human interventions. This study investigated river heatwaves in the Vistula River Basin, one of the largest river systems in Europe using long-term observed daily river water temperatures from the past 30 years (1991-2020). The results showed that river heatwaves are increased in frequency and intensity in the Vistula River Basin. The total number of river heatwaves showed clear increasing trend with an average rate of 1.400 times/decade, the duration of river heatwaves increased at an average rate of 14.506 days/decade, and the cumulative intensity of river heatwaves increased at an average rate of 53.169 °C/decade. The Mann-Kendall (MK) test was also employed, showing statistically significant increasing trends in the total number, duration, and intensity of heatwaves for all rivers, including the main watercourse of the Vistula River and its tributaries, with few exceptions. Air temperature is the major controller of river heatwaves for each hydrological station, and with the increase of air temperatures, river heatwaves will increase in frequency and intensity. Another impacting factor is flow, and with the increase of flow, river heatwaves tend to decrease in number, duration and intensity. The results suggested that mitigation measures shall be taken to reduce the effect of climate change on river systems.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    推荐的血管活性药物在食管静脉曲张破裂出血(EVB)中的持续时间为2-5天。先前对随机试验的荟萃分析仅包括少数比较短与短的研究。长的血管活性药物持续时间接近这个时间范围,包括较旧的管理技术,仅在第5天评估静脉曲张再出血。我们确定了几个额外的随机对照试验(RCT)评估不同持续时间的再出血,随着EVB的更新管理。
    我们进行了最新的系统评价和荟萃分析,评估了血管活性药物持续时间缩短48-72小时的效果。主要结果是5天内再出血。次要结果包括再出血,再出血导致的死亡率,通过血管活性药物和内镜治疗类型的亚组分析,以及4-6周内(延长期)的全因死亡率。逗留时间,输血需求和特利加压素相关不良事件是额外的次要结局.
    我们全面的搜索策略和筛选过程产生了14项随机对照试验,共1060名患者(75.1%为男性):7项试验使用特利加压素,4奥曲肽,和3生长抑素。持续时间缩短加上绑带结扎导致类似的再出血,当排除患有更严重肝病的人群时,出现了减少再出血的趋势。当更短的持续时间联合硬化治疗时,再出血和死亡率更高。更长的持续时间与更长的住院时间有关,对于特利加压素,更多的不良事件。
    在选定的人群中,较短的血管活性药物持续时间与带状结扎相结合似乎是安全的。需要更高功率的RCT,累及不同程度的EVB和肝脏疾病患者。
    UNASSIGNED: The recommended duration of vasoactive drugs in esophageal variceal bleeding (EVB) spans 2-5 days. Prior meta-analyses of randomized trials include only a few studies that compared short vs. long vasoactive drug durations approximating this time range, including older management techniques, and only assessed variceal rebleeding at 5 days. We identified several additional randomized controlled trials (RCTs) assessing rebleeding at various durations, with updated management of EVB.
    UNASSIGNED: We performed an updated systematic review and meta-analysis assessing the effect of shortening the vasoactive drug duration by 48-72 h. The primary outcome was rebleeding within 5 days. Secondary outcomes included rebleeding, mortality due to rebleeding, and all-cause mortality within 4-6 weeks (extended period) with subgroup analysis by vasoactive drug and type of endoscopic therapy. Length of stay, blood transfusion requirements and terlipressin-related adverse events were additional secondary outcomes.
    UNASSIGNED: Our comprehensive search strategy and screening process yielded 14 RCTs with 1060 patients (75.1% male): 7 trials used terlipressin, 4 octreotide, and 3 somatostatin. Shortened durations combined with band ligation led to similar rebleeding, with a trend towards less rebleeding when populations with more severe liver disease were excluded. There was greater rebleeding and mortality over an extended period when shorter durations were combined with sclerotherapy. Longer durations were associated with a longer hospital stay and, for terlipressin, more adverse events.
    UNASSIGNED: Shorter vasoactive drug durations combined with band ligation in selected populations appear safe. Higher powered RCTs are needed, involving patients with different degrees of severity of EVB and liver disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    了解第二语言(L2)学习者在词汇语调感知中面临的挑战对于有效的语言习得至关重要。本研究调查了夸张的声学特性对促进英语使用者普通话音调学习的影响。使用合成的音调刺激,我们通过三个关键修改系统地操纵音高轮廓:扩展基频(F0),增加F0(女性声音),并延长整体持续时间。我们的目标是评估F0扩张的影响,F0越高,持续时间越长,以及不同音节对普通话声调学习和概括的影响。参与者从事非适应性逐个试验的语气识别任务。混合效应逻辑回归模型用于分析各学习阶段的准确性,声学因素,和音调。研究结果表明,从训练到测试和概括阶段,准确性得到了提高,表明感知训练对成人英语使用者的语调感知的有效性。音调1是最容易感知的,而音调3构成了最大的挑战,与已建立的音调获取难度等级一致。声学因素分析突出了音调特定的影响。扩大的F0有利于音调2和音调3的鉴定,但对音调1和音调4提出了挑战。此外,更长的持续时间也表现出不同的效果,帮助识别音调3和音调4,但阻碍音调1识别。较高的F0对音调2有利,但对音调3不利。此外,音节ma促进了音调1和音调2的识别,但不适用于音调3和音调4。这些发现增强了我们对声学特性在L2音调感知中的作用的理解,并对设计有效的第二语言习得训练计划具有意义。
    Understanding the challenges faced by second language (L2) learners in lexical tone perception is crucial for effective language acquisition. This study investigates the impact of exaggerated acoustic properties on facilitating Mandarin tone learning for English speakers. Using synthesized tone stimuli, we systematically manipulated pitch contours through three key modifications: expanding the fundamental frequency (F0), increasing F0 (female voice), and extending the overall duration. Our objectives were to assess the influence of F0 expansion, higher F0, longer duration, and varied syllables on Mandarin tone learning and generalization. Participants engaged in a non-adaptive trial-by-trial tone identification task. Mixed-effects logistic regression modeling was used to analyze accuracy across learning phases, acoustic factors, and tones. Findings reveal improvements in accuracy from training to testing and generalization phases, indicating the effectiveness of perceptual training to tone perception for adult English speakers. Tone 1 emerged as the easiest to perceive, while Tone 3 posed the most challenge, consistent with established hierarchies of tonal acquisition difficulty. Analysis of acoustic factors highlighted tone-specific effects. Expanded F0 was beneficial for the identification of Tone 2 and Tone 3 but posed challenges for Tone 1 and Tone 4. Additionally, longer durations also exhibited varied effects across tones, aiding in the identification of Tone 3 and Tone 4 but hindering Tone 1 identification. The higher F0 was advantageous for Tone 2 but disadvantageous for Tone 3. Furthermore, the syllable ma facilitated the identification of Tone 1 and Tone 2 but not for Tone 3 and Tone 4. These findings enhance our understanding of the role of acoustic properties in L2 tone perception and have implications for the design of effective training programs for second language acquisition.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:没有强有力的证据表明肺康复(PR)计划的最佳持续时间。该研究的目的是确定在改善慢性阻塞性肺疾病(COPD)患者的耐力运动能力方面,8周的PR计划是否等同于12周的PR计划。
    方法:COPD患者随机分为8周(8周)或12周(12周),每周两次,监督公关计划,包括耐力和力量训练以及个性化的自我管理教育。在完成每个程序时进行组间比较(即,第8周或第12周),在第12周和6-12个月的随访中,这两个项目。主要结果是通过耐力穿梭行走测试(ESWT)测量的耐力运动能力,最低重要差异为186s作为等效极限。
    结果:66名参与者[平均值(SD);年龄69(7)岁,FEV148(17)%预测]随机分组(每组33个)。组间比较表明,12周小组的ESWT时间与计划完成时的8周小组相当[平均值(95%CI)][71s(-61至203)],第12周[70秒(-68至208)],和6-12个月的随访[93s(-52至239)],尽管在每个时间点都不能排除12周小组的优越性。
    结论:在8至12周的PR计划中,耐力运动能力表现出等效性,但是不能排除12周小组的优势。关于节目持续时间的决定可能取决于当地候补名单的时间,医疗保健预算和患者偏好。
    OBJECTIVE: There is no strong evidence on the optimal duration of pulmonary rehabilitation (PR) programmes. The aim of the study was to determine whether an 8-week PR programme was equivalent to a 12-week PR programme in improving endurance exercise capacity in people with chronic obstructive pulmonary disease (COPD).
    METHODS: Participants with COPD were randomized to either an 8-week (8-wk Group) or 12-week (12-wk Group), twice weekly, supervised PR programme consisting of endurance and strength training and individualized self-management education. Between group comparisons were made at completion of each programme (i.e., week 8 or week 12), for both programmes at week 12, and at 6-12-month follow-up. The primary outcome was endurance exercise capacity measured by the endurance shuttle walk test (ESWT) with the minimally important difference of 186 s set as the equivalence limit.
    RESULTS: Sixty-six participants [mean (SD); age 69 (7) years, FEV1 48 (17) %predicted] were randomized (33 per group). Between-group comparisons demonstrated that the ESWT time was equivalent for the 12-wk Group compared to the 8-wk Group at programme completion [mean (95% CI)] [71 s (-61 to 203)], week 12 [70 s (-68 to 208)], and 6-12-month follow-up [93 s (-52 to 239)], though superiority of the 12-wk Group could not be ruled out at each time point.
    CONCLUSIONS: Equivalence was shown between 8-and 12-week PR programmes for endurance exercise capacity, but superiority could not be ruled out for the 12-wk Group. Decisions about programme duration may depend on local waitlist times, healthcare budgets and patient preference.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    先前的研究表明,从宫颈成熟球囊放置到分娩的时间较短,总球囊放置时间较短,但排除了先前剖宫产的患者。
    要评估,在有剖宫产史的患者中,使用双球囊导管进行宫颈成熟,计划在6小时和12小时后移除装置是否会导致更短的阴道分娩时间。
    在2020年11月发生实践变化后进行了前后研究,将双气囊导管放置宫颈成熟的计划时间从12小时缩短至6小时。通过回顾性电子图表审查收集数据。主要结果是从球囊放置到阴道分娩的时间。次要结果包括剖宫产率,产妇羊膜腔内感染,还有子宫破裂.Kaplan-Meier曲线比较了两组之间的中位分娩时间。Cox比例风险模型用于调整球囊放置时间,以前阴道分娩的次数,和共同使用的药物。
    从2018年11月至2022年11月,189名有剖宫产史的可分析患者在分娩试验期间接受了双球囊导管促宫颈成熟。将患者分为政策变更前和政策变更后的组(分别为91和98)。前组阴道分娩的中位时间为28小时(95%CI:26,35),后组为25小时(95%CI:23,29)(P值0.052)。在球囊放置时调整扩张后,以前阴道分娩的次数,和共同用药,政策变更后阴道分娩成功的估计风险比为1.89(95%CI:1.27,2.81).次要结局率没有差异。
    在先前剖腹产的患者中,使用双气囊导管进行机械性宫颈成熟,与12小时相比,计划在6小时切除可能会导致更高的成功阴道分娩的机会和更短的分娩时间,不增加剖宫产和羊膜腔内感染的发生率。
    UNASSIGNED: Previous studies that suggest a shorter time from cervical ripening balloon placement to delivery with shorter total balloon placement time have excluded patients with prior cesarean deliveries.
    UNASSIGNED: To evaluate, in patients with a prior history of cesarean delivery undergoing cervical ripening with a double-balloon catheter, whether planned removal of device after 6 vs 12 hours would result in shorter time to vaginal delivery.
    UNASSIGNED: A before-and-after study was performed after a practice change occurred November 2020, shortening the planned time of double-balloon catheter placement for cervical ripening from 12 to 6 hours. Data were collected via retrospective electronic chart review. Primary outcome was time from balloon placement to vaginal delivery. Secondary outcomes included rates of cesarean delivery, maternal intraamniotic infection, and uterine rupture. Kaplan-Meier curves compared median times to delivery between the groups. A Cox proportional-hazards model was used to adjust for time of balloon placement, number of previous vaginal deliveries, and co-medications used.
    UNASSIGNED: From November 2018 to November 2022, 189 analyzable patients with a prior history of cesarean delivery received a double-balloon catheter for cervical ripening during their trial of labor. Patients were separated into pre- and postpolicy change groups (n=91 and 98, respectively). The median time to vaginal delivery for the pregroup was 28 hours (95% CI: 26, 35) and 25 hours (95% CI: 23, 29) for those in the postgroup (P value .052). After adjusting for dilation at time of balloon placement, number of previous vaginal deliveries, and co-medication, the estimated hazard ratio for successful vaginal delivery postpolicy change was 1.89 (95% CI: 1.27, 2.81). There were no differences in rates of secondary outcomes.
    UNASSIGNED: In patients with prior cesarean delivery undergoing mechanical cervical ripening with a double-balloon catheter, planned removal at 6 hours compared to 12 hours may result in higher chances of successful vaginal delivery and possibly a shorter time to delivery, without increasing rates of cesarean delivery and intraamniotic infection.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:雄激素剥夺治疗(ADT)与术后放疗(RT)的使用和持续时间尚不确定。RADICALS-HD比较添加不(“无”),6个月(“短”),或24个月(“长”)ADT以长期研究疗效。
    方法:前列腺癌患者接受了术后放疗,并在所有持续时间之间进行了一致的随机分组。ADT分配给0、6或24个月。主要结果指标(OM)为无转移生存期(MFS)。继发性OMs包括无远处转移,总生存率,并启动非协议ADT。通过双向比较确定样本量。分析遵循标准的事件时间方法和意向治疗原则。
    在2007年至2015年之间,492名参与者被随机分为三组:166名,164短,162长随机分组的中位年龄为66岁;手术时的格里森评分如下:<7=64(13%),3+4=229(47%),4+3=127(26%),8+=72(15%);T3b为112(23%);T4为5(1%)。中位随访时间为9.0年,报告了89名参与者的MFS事件(32无,31短,和26长),整体MFS没有差异的证据(logrankp=0.98),and,长与无,风险比=0.948(95%置信区间0.54-1.68)。10年后,80%无,77%短,81%的Long患者存活,无转移性疾病。三向随机化没有被授权到常规水平进行评估,但提供了一个公平的比较。
    结论:前列腺癌根治术后的长期结局通常是有利的。在那些需要进行术后RT并被认为不适合的患者中,短期,或长期ADT,没有证据表明ADT的增加有改善.未来的研究应集中于转移风险较高的患者,这些患者更迫切需要改善。
    OBJECTIVE: The use and duration of androgen deprivation therapy (ADT) with postoperative radiotherapy (RT) have been uncertain. RADICALS-HD compared adding no (\"None\"), 6-months (\"Short\"), or 24-mo (\"Long\") ADT to study efficacy in the long term.
    METHODS: Participants with prostate cancer were indicated for postoperative RT and agreed randomisation between all durations. ADT was allocated for 0, 6, or 24 mo. The primary outcome measure (OM) was metastasis-free survival (MFS). The secondary OMs included freedom from distant metastasis, overall survival, and initiation of nonprotocol ADT. Sample size was determined by two-way comparisons. Analyses followed standard time-to-event approaches and intention-to-treat principles.
    UNASSIGNED: Between 2007 and 2015, 492 participants were randomised one of three groups: 166 None, 164 Short, and 162 Long. The median age at randomisation was 66 yr; Gleason scores at surgery were as follows: <7 = 64 (13%), 3+4 = 229 (47%), 4+3 = 127 (26%), and 8+ = 72 (15%); T3b was 112 (23%); and T4 was 5 (1%). The median follow-up was 9.0 yr and, with MFS events reported for 89 participants (32 None, 31 Short, and 26 Long), there was no evidence of difference in MFS overall (logrank p = 0.98), and, for Long versus None, hazard ratio = 0.948 (95% confidence interval 0.54-1.68). After 10 yr, 80% None, 77% Short, and 81% Long patients were alive without metastatic disease. The three-way randomisation was not powered to conventional levels for assessment, yet provides a fair comparison.
    CONCLUSIONS: Long-term outcomes after radical prostatectomy are usually favourable. In those indicated for postoperative RT and considered suitable for no, short-term, or long-term ADT, there was no evidence of improvement with addition of ADT. Future research should focus on patients at a higher risk of metastases in whom improvements are required more urgently.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在区域气候变化的背景下,西北地区的沙尘事件变得更加多变。先前的研究在很大程度上忽略了沙尘事件持续时间(DED)的时空分布及其长期趋势。本研究系统分析了中国西北地区DED的时空变化,并利用2000-2021年期间的卫星空气质量数据集探讨了其相关因素。我们发现,自2000年以来,沙尘事件频率(DEF)和DED总体上呈显著下降趋势,但在2013年,DEF和DED开始反弹。特别是DED,在中国西北大部分地区表现出更明显的反弹。与许多因素的相关性分析表明,自2013年以来近地表风速的上升可能主要是通过增强粉尘生成和抑制粉尘干沉积过程来导致DEF和DED的增加。进一步的预测显示,靠近尘源的地区可能会发生更频繁和更长时间的尘土事件,而远离尘源的地区未来DEF和DED将下降。这些发现对于了解粉尘事件变化和指导当地粉尘管理策略至关重要。
    Dust events in Northwest China have become more variable under regional climate change. Prior research has largely overlooked the spatial-temporal distribution of dust event duration (DED) and its long-term trend. This study systematically analyzed the spatial and temporal variations of DED in Northwest China and explored their associated factors using satellite-derived air quality datasets during 2000-2021. We find that dust event frequency (DEF) and DED generally showed a significant decreasing trend since 2000, but in 2013, DEF and DED started to rebound, with DED in particular, showing a more pronounced rebound in most parts of Northwest China. Correlation analysis with many factors suggests that the rise in near-surface wind speed since 2013 may primarily account for the increase in DEF and DED by enhancing dust generation and suppressing dust dry deposition processes. Further projections reveal that regions close to dust sources are likely to have more frequent and prolonged dust events, while areas far from dust sources will experience a decrease in DEF and DED in the future. These findings are crucial for understanding dust event variations and for guiding local dust management strategies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在逆行肾内手术(RIRS)之前放置的JJ支架可以简化手术。然而,需要注意的是,在RIRS之前延长双J支架(DJS)置入时间可能会增加术后尿路感染(UTI)的风险.各种出版物都建立了这个协会,尽管手术前DJS的持续时间很少。我们的研究调查了支架置入前与术后UTI之间的关系,并建立了一个截止期以最大程度地降低这种风险。我们共纳入500例术前DJSRIRS。根据患者术前支架置入时间分为五组(第1组:0-15天;第2组:16-30天;第3组:31-45天;第4组:46-60天;第5组:>60天)。患者的人口统计学和临床数据,石材性质,操作数据,围手术期和术后并发症(包括发热和UTI),住院时间,比较无石率(SFR)。该组包括53、124、102、63和158名患者。各组患者的人口统计学特征相似。DJS持续时间无统计学差异,围手术期/术后并发症,SFR,除了输尿管入路鞘(UAS)插入率。(p=0.001)。与其他持续时间相比,第1组的术后发热/UTI发生率最低(p=0.046)。支架持续时间不影响SFR。较长的支架可提高UAS插入成功率,但增加术后感染风险。我们的结果表明RIRS应该在两周内进行,理想情况下,支架插入后20天,降低术后感染风险。
    A JJ stent placed before retrograde intrarenal surgery (RIRS) may ease the procedure. However, it is important to note that a prolonged duration of double J stent (DJS) placement before RIRS may increase the risk of postoperative urinary tract infection (UTI). Various publications have established this association, although the duration of the DJS before surgery is scarce. Our study investigates the relationship between the pre-stenting period and postoperative UTI and establishes a cut-off period to minimize this risk. We included a total of 500 cases with preoperative DJS prior to RIRS. The patients were divided into five groups according to their preoperative stenting duration (Group 1: 0-15 days; Group 2: 16-30 days; Group 3: 31-45 days; Group 4: 46-60 days; Group 5: >60 days). Demographic and clinical data of the patients, stone properties, operation data, perioperative and postoperative complications (including fever and UTI), hospitalization time, and stone-free rates (SFR) were compared. The groups contained 53, 124, 102, 63, and 158 patients. The demographics of the patients in each group were similar. There was no statistically significant difference between DJS duration, perioperative/postoperative complications, and SFR, except for the ureteral access sheath (UAS) insertion rate. (p = 0.001). The postoperative fever/UTI rate was the lowest in Group 1 (p = 0.046) compared to other durations. Stent duration does not impact SFR. Longer stents enhance UAS insertion success but increase postoperative infection risk. Our results suggest that RIRS should be performed within two weeks, ideally 20 days following stent insertion, to minimize postoperative infection risk.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号